Department of Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
Nat Commun. 2020 Dec 22;11(1):6442. doi: 10.1038/s41467-020-20221-0.
In addition to the serotonin 5-HT receptor (5-HTR), the dopamine D receptor (DR) is a key therapeutic target of antipsychotics for the treatment of schizophrenia. The inactive state structures of DR have been described in complex with the inverse agonists risperidone (DR) and haloperidol (DR). Here we describe the structure of human DR in complex with spiperone (DR). In DR, the conformation of the extracellular loop (ECL) 2, which composes the ligand-binding pocket, was substantially different from those in DR and DR, demonstrating that ECL2 in DR is highly dynamic. Moreover, DR exhibited an extended binding pocket to accommodate spiperone's phenyl ring, which probably contributes to the selectivity of spiperone to DR and 5-HTR. Together with DR and DR, the structural information of DR should be of value for designing novel antipsychotics with improved safety and efficacy.
除了血清素 5-HT 受体 (5-HTR),多巴胺 D 受体 (DR) 也是治疗精神分裂症的抗精神病药物的一个关键治疗靶点。DR 的无活性状态结构已与非典型抗精神病药利培酮 (DR) 和氟哌啶醇 (DR) 复合被描述过。在这里,我们描述了人源 DR 与哌罗匹隆 (DR) 复合的结构。在 DR 中,构成配体结合口袋的细胞外环 (ECL) 2 的构象与 DR 和 DR 中的构象有很大不同,表明 DR 中的 ECL2 具有高度的动态性。此外,DR 表现出扩展的结合口袋以容纳哌罗匹隆的苯环,这可能有助于哌罗匹隆对 DR 和 5-HTR 的选择性。与 DR 和 DR 一起,DR 的结构信息对于设计具有更好安全性和疗效的新型抗精神病药物应该具有重要价值。